M N Stojanovic1, P de Prada, D W Landry
1Division of Clinical Pharmacology and Experimental Therapeutics, Department of Medicine, Columbia University, Box 84, 630W 168th Street, New York, NY 10032, USA. mns18@columbia.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Researchers developed catalytic molecular beacons using deoxyribozymes. This modular design enables precise detection of target oligonucleotides, activating catalytic cleavage for sensitive analysis and potential drug delivery applications.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: